These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 28642330)

  • 1. Effects of Intensive BP Control in CKD.
    Cheung AK; Rahman M; Reboussin DM; Craven TE; Greene T; Kimmel PL; Cushman WC; Hawfield AT; Johnson KC; Lewis CE; Oparil S; Rocco MV; Sink KM; Whelton PK; Wright JT; Basile J; Beddhu S; Bhatt U; Chang TI; Chertow GM; Chonchol M; Freedman BI; Haley W; Ix JH; Katz LA; Killeen AA; Papademetriou V; Ricardo AC; Servilla K; Wall B; Wolfgram D; Yee J;
    J Am Soc Nephrol; 2017 Sep; 28(9):2812-2823. PubMed ID: 28642330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.
    Williamson JD; Supiano MA; Applegate WB; Berlowitz DR; Campbell RC; Chertow GM; Fine LJ; Haley WE; Hawfield AT; Ix JH; Kitzman DW; Kostis JB; Krousel-Wood MA; Launer LJ; Oparil S; Rodriguez CJ; Roumie CL; Shorr RI; Sink KM; Wadley VG; Whelton PK; Whittle J; Woolard NF; Wright JT; Pajewski NM;
    JAMA; 2016 Jun; 315(24):2673-82. PubMed ID: 27195814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality Outcomes With Intensive Blood Pressure Targets in Chronic Kidney Disease Patients.
    Aggarwal R; Petrie B; Bala W; Chiu N
    Hypertension; 2019 Jun; 73(6):1275-1282. PubMed ID: 31067189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease: A Secondary Analysis of a Randomized Trial.
    Beddhu S; Rocco MV; Toto R; Craven TE; Greene T; Bhatt U; Cheung AK; Cohen D; Freedman BI; Hawfield AT; Killeen AA; Kimmel PL; Lash J; Papademetriou V; Rahman M; Rastogi A; Servilla K; Townsend RR; Wall B; Whelton PK;
    Ann Intern Med; 2017 Sep; 167(6):375-383. PubMed ID: 28869987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age and Outcomes Associated with BP in Patients with Incident CKD.
    Kovesdy CP; Alrifai A; Gosmanova EO; Lu JL; Canada RB; Wall BM; Hung AM; Molnar MZ; Kalantar-Zadeh K
    Clin J Am Soc Nephrol; 2016 May; 11(5):821-831. PubMed ID: 27103623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Blood Pressure Control on Long-Term Risk of End-Stage Renal Disease and Death Among Subgroups of Patients With Chronic Kidney Disease.
    Ku E; Sarnak MJ; Toto R; McCulloch CE; Lin F; Smogorzewski M; Hsu CY
    J Am Heart Assoc; 2019 Aug; 8(16):e012749. PubMed ID: 31411082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Blood Pressure With the Progression of CKD: Findings From KNOW-CKD Study.
    Lee JY; Park JT; Joo YS; Lee C; Yun HR; Yoo TH; Kang SW; Choi KH; Ahn C; Oh KH; Sung S; Kim SW; Lee J; Han SH;
    Am J Kidney Dis; 2021 Aug; 78(2):236-245. PubMed ID: 33444666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL Trial.
    Tuttle KR; Dworkin LD; Henrich W; Greco BA; Steffes M; Tobe S; Shapiro JI; Jamerson K; Lyass A; Pencina K; Massaro JM; D'Agostino RB; Cutlip DE; Murphy TP; Cooper CJ
    Clin J Am Soc Nephrol; 2016 Jul; 11(7):1180-1188. PubMed ID: 27225988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of blood pressure-lowering treatment by the levels of baseline Framingham risk score: A post hoc analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
    Zhang L; Sun X; Liao L; Zhang S; Zhou H; Zhong X; Zhuang X; Liao X
    J Clin Hypertens (Greenwich); 2019 Dec; 21(12):1813-1820. PubMed ID: 31670874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney, Cardiac, and Safety Outcomes Associated With α-Blockers in Patients With CKD: A Population-Based Cohort Study.
    Hundemer GL; Knoll GA; Petrcich W; Hiremath S; Ruzicka M; Burns KD; Edwards C; Bugeja A; Rhodes E; Sood MM
    Am J Kidney Dis; 2021 Feb; 77(2):178-189.e1. PubMed ID: 32920153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of cumulative SBP and serious adverse events on efficacy of intensive blood pressure treatment: a randomized clinical trial.
    Rueda-Ochoa OL; Rojas LZ; Ahmad S; van Duijn CM; Ikram MA; Deckers JW; Franco OH; Rizopoulos D; Kavousi M
    J Hypertens; 2019 May; 37(5):1058-1069. PubMed ID: 30444838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intensive blood-pressure control in type 2 diabetes mellitus.
    ; Cushman WC; Evans GW; Byington RP; Goff DC; Grimm RH; Cutler JA; Simons-Morton DG; Basile JN; Corson MA; Probstfield JL; Katz L; Peterson KA; Friedewald WT; Buse JB; Bigger JT; Gerstein HC; Ismail-Beigi F
    N Engl J Med; 2010 Apr; 362(17):1575-85. PubMed ID: 20228401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Intensive Blood Pressure Lowering on Kidney Tubule Injury in CKD: A Longitudinal Subgroup Analysis in SPRINT.
    Malhotra R; Craven T; Ambrosius WT; Killeen AA; Haley WE; Cheung AK; Chonchol M; Sarnak M; Parikh CR; Shlipak MG; Ix JH;
    Am J Kidney Dis; 2019 Jan; 73(1):21-30. PubMed ID: 30291012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender, blood pressure, and cardiovascular and renal outcomes in adults with hypertension from the Systolic Blood Pressure Intervention Trial.
    Foy CG; Lovato LC; Vitolins MZ; Bates JT; Campbell R; Cushman WC; Glasser SP; Gillespie A; Kostis WJ; Krousel-Wood M; Muhlestein JB; Oparil S; Osei K; Pisoni R; Segal MS; Wiggers A; Johnson KC;
    J Hypertens; 2018 Apr; 36(4):904-915. PubMed ID: 29493562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Prediabetes on the Effects of Intensive Systolic Blood Pressure Control on Kidney Events.
    Rathi N; Whelton PK; Chertow GM; Cushman WC; Cheung AK; Wei G; Boucher R; Kimmel PL; Bress AP; Kramer HJ; Al-Marji C; Greene T; Beddhu S
    Am J Hypertens; 2019 Nov; 32(12):1170-1177. PubMed ID: 31257407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systolic blood pressure levels among adults with hypertension and incident cardiovascular events: the atherosclerosis risk in communities study.
    Rodriguez CJ; Swett K; Agarwal SK; Folsom AR; Fox ER; Loehr LR; Ni H; Rosamond WD; Chang PP
    JAMA Intern Med; 2014 Aug; 174(8):1252-61. PubMed ID: 24935209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of baseline systolic blood pressure on the relationship between intensive blood pressure control and cardiovascular outcomes in the Systolic Blood Pressure Intervention Trial (SPRINT).
    Sun X; Guo Y; Nie Z; Cheng J; Zhou H; Zhong X; Zhang S; Du Z; Zhuang X; Liao X
    Clin Res Cardiol; 2019 Mar; 108(3):273-281. PubMed ID: 30167807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Baseline Kidney Function on the Risk of Recurrent Stroke and on Effects of Intensive Blood Pressure Control in Patients With Previous Lacunar Stroke: A Post Hoc Analysis of the SPS3 Trial (Secondary Prevention of Small Subcortical Strokes).
    Agarwal A; Cheung AK; Ma J; Cho M; Li M
    J Am Heart Assoc; 2019 Aug; 8(16):e013098. PubMed ID: 31423869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney Disease, Hypertension Treatment, and Cerebral Perfusion and Structure.
    Kurella Tamura M; Gaussoin S; Pajewski NM; Zaharchuk G; Freedman BI; Rapp SR; Auchus AP; Haley WE; Oparil S; Kendrick J; Roumie CL; Beddhu S; Cheung AK; Williamson JD; Detre JA; Dolui S; Bryan RN; Nasrallah IM;
    Am J Kidney Dis; 2022 May; 79(5):677-687.e1. PubMed ID: 34543687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The SPRINT Research. A Randomized Trial of Intensive versus Standard Blood-Pressure Control].
    Widimský J
    Vnitr Lek; 2016 Jan; 62(1):44-7. PubMed ID: 26967236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.